Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19

NCT04486508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: intermediate dose Enoxaparin/ unfractionated heparin
DRUG: standard prophylactic dose Enoxaparin/ unfractionated heparin
DRUG: Atorvastatin 20mg
DRUG: Matched placebo

Sponsor

Rajaie Cardiovascular Medical and Research Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]